Stay updated with breaking news from Pfizer Ignite. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
2023 Sets Stage for Future Growth Potential: Completed Seagen Acquisition, Creating World-Class Oncology Organization; Launched Significant Number of New Products and Indications; and Realigned...
CAMBRIDGE, Mass., October 25, 2023 - Mediar Therapeutics Inc., a biotechnology company advancing a portfolio of first-in-class therapies that halt fibrosis progression, today announced several...
/PRNewswire/ -- About 9.4% of the world population is aged 65 or above. Older people typically consume more medicines than the people in other age group...
/PRNewswire/ -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug...
By Adam L. Cataldo Cardiff Oncology's shares climbed after the company said it would advance its lead program--a possible treatment for colorectal...